Abstract
CMV infection remains a cause of death in heart transplantation (HT). IgG hypogammaglobulinemia is a risk factor of this complication. We assessed IgG immune reconstitution after inespecific intravenous immunoglobulin (IVIG) replacement therapy for secondary IgG hypogammaglobulinemia (HGG) in heart recipients with post-transplant CMV infection.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
